Global Human Milk Oligosaccharides (HMO) Competitive Landscape Professional Research Report 2025

Research Summary

Human Milk Oligosaccharides (HMOs) are a complex group of naturally occurring carbohydrates found in human breast milk. These compounds are the third most abundant solid component in breast milk after lactose and lipids. HMOs serve essential functions in supporting the health and development of infants. While infants cannot directly digest HMOs, they act as prebiotics, promoting the growth and activity of beneficial bacteria in the infant＇s gut, particularly Bifidobacteria. This prebiotic effect contributes to the development of a healthy gut microbiome, which, in turn, plays a crucial role in immune system development and overall well-being. HMOs also have antimicrobial properties, preventing the attachment of harmful pathogens to the intestinal lining. Research suggests that HMOs may offer various health benefits, including immune system support, protection against infections, and positive effects on cognitive development. Due to their potential health-promoting properties, HMOs have become an area of interest in infant formula research as scientists seek to mimic the composition of breast milk for formula-fed infants.

According to DIResearch's in-depth investigation and research, the global Human Milk Oligosaccharides (HMO) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Human Milk Oligosaccharides (HMO). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Human Milk Oligosaccharides (HMO) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Human Milk Oligosaccharides (HMO) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Milk Oligosaccharides (HMO) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Human Milk Oligosaccharides (HMO) Include:

Abbott

Inbiose

Glycom

Chr. Hansen (Jennewein)

Elicityl SA

ZuChem

Human Milk Oligosaccharides (HMO) Product Segment Include:

2＇-FL & 3-FL

LNT & LNnT, etc.

Human Milk Oligosaccharides (HMO) Product Application Include:

Infant Formula

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Human Milk Oligosaccharides (HMO) Industry PESTEL Analysis

Chapter 3: Global Human Milk Oligosaccharides (HMO) Industry Porter’s Five Forces Analysis

Chapter 4: Global Human Milk Oligosaccharides (HMO) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Human Milk Oligosaccharides (HMO) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Human Milk Oligosaccharides (HMO) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Human Milk Oligosaccharides (HMO) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Human Milk Oligosaccharides (HMO) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Human Milk Oligosaccharides (HMO) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Human Milk Oligosaccharides (HMO) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Human Milk Oligosaccharides (HMO) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Human Milk Oligosaccharides (HMO) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources